Medicare Part D Premium Support Could End, Raising Cost Concerns for Seniors
Millions of Americans enrolled in Medicare Part D could soon face higher monthly prescription drug premiums after the Centers for Medicare & Medicaid Services (CMS) announced it will end a temporary premium stabilization program after 2026. The subsidy was introduced in 2024 to help insurers adjust to major Medicare drug benefit changes under the Inflation Reduction Act, but federal officials now say the program has served its purpose. While CMS expects most beneficiaries to see only modest premium changes, advocates warn even relatively small increases could matter for seniors living on fixed incomes.
Why the Subsidy Was Created in the First Place
The premium support program was launched by the Biden administration after the Inflation Reduction Act reshaped Medicare Part D. The law introduced significant changes, including new limits on beneficiaries’ annual out-of-pocket prescription costs and other benefit redesigns that created uncertainty for insurers setting premiums. The temporary subsidy helped stabilize the market while insurers adjusted to the new system. CMS now says insurers have gained enough experience to price plans without additional federal support.
What the Trump Administration Says Will Happen
CMS Administrator Dr. Mehmet Oz defended ending the subsidy, arguing it would stop billions of taxpayer dollars from flowing to insurance companies unnecessarily. The agency estimates the program cost approximately $3.6 billion in 2026. Oz said most Medicare beneficiaries should see premium increases of less than $10 per month, while some may even pay lower premiums depending on the plans available in their area. CMS also emphasized that affordable plan options will remain available nationwide.
Critics Say Even Small Increases Can Hurt
Critics argue that average figures do not reflect what many seniors experience in their monthly budgets. Senate Minority Leader Chuck Schumer criticized the decision, saying it would increase prescription drug costs for millions of older Americans. Juliette Cubanski, director of Medicare policy at KFF, noted that even modest premium increases become more significant when combined with rising costs for housing, groceries and transportation. For retirees living on fixed incomes, every additional monthly expense can affect household finances.
Not Everyone Will Pay the Same Amount
One important detail is that Medicare Part D premiums vary depending on the plan a beneficiary chooses and where they live. According to projections released by the Trump administration, about 25% of people enrolled in standalone Medicare Part D plans are expected to see their monthly premiums stay the same or even decrease after the stabilization program ends. Another 30% are projected to pay less than $10 more per month, while the largest group, 45%, could see increases ranging from $11 to $20 per month. Final 2027 premiums will be released by CMS in September, so individual costs will vary based on the plans available in each region and the choices beneficiaries make during Medicare Open Enrollment.
One Major Protection Is Staying in Place
Although premiums may change, one of the Inflation Reduction Act’s biggest consumer protections remains intact. The annual cap on out-of-pocket prescription drug spending is expected to increase from $2,100 in 2026 to about $2,400 in 2027, limiting how much beneficiaries pay directly for covered medications over the course of a year. The federal Medicare drug price negotiation program also remains in effect, continuing efforts to lower the prices of certain high-cost medications.
The Biggest Question Is Still Unanswered
Exactly how many people will pay higher premiums remains unknown. According to KFF, roughly 25 million Americans were enrolled in standalone Medicare Part D plans in 2026, but each plan sets its own premiums. CMS has said it will publish the final 2027 Medicare Advantage and Part D premiums and plan details in September, giving beneficiaries time to compare options before enrollment begins.
Shopping Around Could Matter More Than Ever
Because Part D plans compete with different premiums, deductibles and drug formularies, experts encourage beneficiaries to compare plans every year rather than automatically renewing their current coverage. A plan that was the least expensive in 2026 may not remain the best value in 2027, particularly if premiums shift after the subsidy expires. Reviewing formularies, pharmacy networks and monthly costs during Open Enrollment could help reduce unexpected expenses.
The Decision Carries Political Stakes Too
The timing also gives the announcement political significance. Beneficiaries are expected to learn their 2027 premiums during the fall, as voters head to the polls in the midterm elections. Democrats argue the decision fits into a wider pattern of reducing healthcare affordability, while the Trump administration says ending the temporary subsidy reflects a stronger, more stable insurance market that no longer requires federal assistance.
September Will Provide the Real Answers
For now, neither supporters nor critics know exactly how much individual seniors will pay next year. That picture will become much clearer once CMS releases final Part D premiums and plan information in September. Until then, beneficiaries can expect a period of close scrutiny as insurers publish their rates and millions of Medicare enrollees begin comparing plans to determine whether their prescription drug coverage will remain affordable in 2027.